Revenue: € 2,861 million in 2008 (+9.6% over 2007 at comparable rate)
11,000 employees worldwide
More than 50% of staff devoted to industrial operations
10 production and/or R&D sites in France, at Marcy l'Etoile and Val de Reuil; in the United States, in Swiftwater (Pennsylvania), Cambridge and Canton (Massachusetts), and Rockville (Maryland); in Argentina, in Pilar; in China, in Shenzhen; and in Thailand, in Chachoengsao
Investment in research and production capacity:
More than 1.6 billion doses of vaccines produced yearly to immunize more than 500 million people in the world
Largest product range available, against 20 infectious diseases
More than 1 million euros invested every day in R&D
Nearly 1.5 billion euros invested in the last 5 years in production capacity